Number needed to treat in cardiovascular outcome trials of glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis

Receptor Agonists ◽

Glucagon Like Peptide ◽

Review for "Number needed to treat in cardiovascular outcome trials with glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis"

10.1111/dom.14066/v1/review2 ◽

2020 ◽

Author(s):

Ling Li

Keyword(s):

Systematic Review ◽

Temporal Analysis ◽

Cardiovascular Outcome ◽

Number Needed To Treat ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Author response for "Number needed to treat in cardiovascular outcome trials with glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis"

10.1111/dom.14066/v2/response1 ◽

2020 ◽

Author(s):

Melanie J Davies ◽

David E Kloecker ◽

David R Webb ◽

Kamlesh Khunti ◽

Francesco Zaccardi

Keyword(s):

Systematic Review ◽

Temporal Analysis ◽

Cardiovascular Outcome ◽

Author Response ◽

Number Needed To Treat ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Decision letter for "Number needed to treat in cardiovascular outcome trials with glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis"

10.1111/dom.14066/v2/decision1 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Temporal Analysis ◽

Cardiovascular Outcome ◽

Number Needed To Treat ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Review for "Number needed to treat in cardiovascular outcome trials with glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis"

10.1111/dom.14066/v1/review3 ◽

2020 ◽

Author(s):

Salvatore Carbone

Keyword(s):

Systematic Review ◽

Temporal Analysis ◽

Cardiovascular Outcome ◽

Number Needed To Treat ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Decision letter for "Number needed to treat in cardiovascular outcome trials with glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis"

10.1111/dom.14066/v1/decision1 ◽

2020 ◽

Keyword(s):

Systematic Review ◽

Temporal Analysis ◽

Cardiovascular Outcome ◽

Number Needed To Treat ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Review for "Number needed to treat in cardiovascular outcome trials with glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis"

10.1111/dom.14066/v1/review1 ◽

2020 ◽

Author(s):

Awadhesh Kumar Singh

Keyword(s):

Systematic Review ◽

Temporal Analysis ◽

Cardiovascular Outcome ◽

Number Needed To Treat ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials With Meta-Analysis

Stroke ◽

10.1161/strokeaha.119.027557 ◽

2020 ◽

Vol 51 (2) ◽

pp. 666-669 ◽

Cited By ~ 4

Author(s):

Giuseppe Bellastella ◽

Maria Ida Maiorino ◽

Miriam Longo ◽

Lorenzo Scappaticcio ◽

Paolo Chiodini ◽

...

Keyword(s):

Systematic Review ◽

Meta Analysis ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Identification of Subpopulations Exhibiting the Greatest Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide-1 Receptor Agonists—A Combined Analysis of Large Cardiovascular Outcome Trials

Diabetes ◽

10.2337/db18-1064-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1064-P

Author(s):

YU MI KANG ◽

YUN KYUNG CHO ◽

JONG HAN CHOI ◽

CHANGYUN WOO ◽

WOO JE LEE ◽

...

Keyword(s):

Cardiovascular Outcome ◽

Combined Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting ◽

Cardiovascular Benefit

Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice: The case of glucagon‐like peptide‐1 receptor agonists

Diabetes Obesity and Metabolism ◽

10.1111/dom.13962 ◽

2020 ◽

Vol 22 (5) ◽

pp. 817-827 ◽

Cited By ~ 9

Author(s):

Veronica Sciannameo ◽

Paola Berchialla ◽

Emanuela Orsi ◽

Olga Lamacchia ◽

Susanna Morano ◽

...

Keyword(s):

Clinical Practice ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials

Diabetes & Metabolism Journal ◽

10.4093/dmj.2018.0070 ◽

2019 ◽

Vol 43 (4) ◽

pp. 410 ◽

Cited By ~ 5

Author(s):

Yu Mi Kang ◽

Yun Kyung Cho ◽

Jiwoo Lee ◽

Seung Eun Lee ◽

Woo Je Lee ◽

...

Keyword(s):

Meta Analysis ◽

Cardiovascular Outcome ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting ◽

Cardiovascular Benefit